All In Biotech

Drug Trial Radar · NCT01072929

A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Last checked: Nov 20, 2026Latest source record: Apr 27, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 433 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

433

Actual

Start

Jan 2010

Primary completion

Mar 2012

Study completion Mar 2012

Sponsor

Lead sponsor
CephalonIndustry
Sponsor type
Industry
First posted
Feb 22, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the study is to determine whether armodafinil treatment, at a dosage of 150 mg/day, is more effective than placebo treatment as adjunctive therapy to mood stabilizers for treatment of adults with major depression associated with bipolar I disorder.

Conditions

  • Depression

Interventions

  • ArmodafinilDrug

    Doses of either 150mg/day or 200 mg/day in tablet form taken orally, once daily in the morning.

  • PlaceboDrug

    Matching Placebo, also in tablet form taken orally, once daily in the morning.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week 8 in the Total Score From the 30-Item Inventory of Depressive Symptomatology-Clinician-Rated (IDS-C30)Time frame: Day 0 (baseline), Week 8

Locations

40 sites in 1 country. Site status is shown where the registry gives one.

  • Birmingham Research Group

    Birmingham, Alabama

  • Southwestern Research

    Beverly Hills, California

  • Collaborative NeuroScience Network

    Garden Grove, California

  • Sun Valley Behavioral Medical

    Imperial, California

  • University of California Irvine

    Irvine, California

  • Excell Research

    Oceanside, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • Clinical Innovations Inc.

    Santa Ana, California

  • Viking Clinical Research Center

    Temecula, California

  • CNS Clinical Research Group - Florida Clinical Research Cent

    Coral Springs, Florida

  • Gulfcoast Clinical Research Center

    Fort Myers, Florida

  • Sarkis Clinical Trials

    Gainesville, Florida

  • Dr. Vijapura and Assoc.

    Jacksonville, Florida

  • Fidelity Clinical Research

    Lauderhill, Florida

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • University of South Florida

    Tampa, Florida

  • Comprehensive Neuroscience, Inc

    Atlanta, Georgia

  • Northwest Behavioral Research Center

    Roswell, Georgia

  • AMR Baber Research Inc.

    Naperville, Illinois

  • American Medical Research

    Oak Brook, Illinois

  • CNS - Comprehensive Neuro Science

    Park Ridge, Illinois

  • Pharmasite Research, Inc

    Baltimore, Maryland

  • AccelRx Research

    Fall River, Massachusetts

  • Mid-America Clinical Research, LLC

    St Louis, Missouri

  • CRI Worldwide, LLC

    Mount Laurel, New Jersey

  • Albequerque Neuroscience

    Albuquerque, New Mexico

  • Social Psychiatry Research Institute

    Brooklyn, New York

  • Eastside Comprehensive Medical Center

    New York, New York

  • Finger Lakes Clinical Research

    Rochester, New York

  • Richmond Behavioral Associates

    Staten Island, New York

  • Richard Weisler, MD and Associates

    Raleigh, North Carolina

  • Charak Clinical Research Center

    Beachwood, Ohio

  • Midwest Clinical Research Center

    Dayton, Ohio

  • Oregon Center for Clinical Investigations, Inc

    Salem, Oregon

  • Suburban Research Associates

    Media, Pennsylvania

  • Scranton Counseling Center

    Scranton, Pennsylvania

  • Carolina Clinical Trials, Inc.

    Charleston, South Carolina

  • Community Clinical Research

    Austin, Texas

  • FutureSearch Trials of Neurology

    Austin, Texas

  • Northwest Clinical Research Center

    Bellevue, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.